Security key
413197104
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 45,933,803
- Share change
- +1,596,943
- Total reported value
- $2,235,023,234
- Price per share
- $48.65
- Number of holders
- 168
- Value change
- +$79,981,090
- Number of buys
- 108
- Number of sells
- 47
Report period
Q1 2022
Institutions
168
Top holders
10
HRMY full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Harmony Biosciences Holdings, Inc. SEC filings
Harmony Biosciences Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 413197104
Recent filing periods:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Valor Management LLC |
13F
|
Company |
19%
|
11,218,033
|
$478,337,000 | — | 31 Dec 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
8.5%
|
4,884,341
|
$208,268,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
7.3%
|
4,207,599
|
$179,412,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.5%
|
3,739,766
|
$159,463,000 | — | 31 Dec 2021 | |
| venBio Partners LLC |
13F
|
Company |
4.8%
|
2,740,411
|
$116,851,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
2,659,085
|
$113,383,000 | — | 31 Dec 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3%
|
1,750,000
|
$74,620,000 | — | 31 Dec 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.7%
|
1,543,724
|
$65,827,000 | — | 31 Dec 2021 | |
| Blackstone Inc. |
13F
|
Company |
1.8%
|
1,048,951
|
$44,727,000 | — | 31 Dec 2021 | |
| Newlight Partners LP |
13F
|
Company |
1.6%
|
900,824
|
$38,411,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
775,683
|
$33,075,000 | — | 31 Dec 2021 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
1.3%
|
768,708
|
$32,778,000 | — | 31 Dec 2021 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
694,783
|
$29,626,000 | — | 31 Dec 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.97%
|
559,868
|
$23,873,000 | — | 31 Dec 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.83%
|
475,824
|
$20,289,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
424,828
|
$18,114,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.67%
|
383,994
|
$16,373,000 | — | 31 Dec 2021 | |
| Aisling Capital Management LP |
13F
|
Company |
0.62%
|
355,415
|
$15,155,000 | — | 31 Dec 2021 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.49%
|
282,034
|
$12,026,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
267,049
|
$11,387,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
240,824
|
$10,269,000 | — | 31 Dec 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.42%
|
239,258
|
$10,202,000 | — | 31 Dec 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.41%
|
236,000
|
$10,063,000 | — | 31 Dec 2021 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.38%
|
220,000
|
$9,528,000 | — | 31 Dec 2021 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.38%
|
219,084
|
$9,342,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.35%
|
199,411
|
$8,503,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
195,121
|
$8,320,000 | — | 31 Dec 2021 | |
| Atle Fund Management AB |
13F
|
Company |
0.34%
|
195,000
|
$8,315,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
171,107
|
$7,297,000 | — | 31 Dec 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.28%
|
158,557
|
$6,761,000 | — | 31 Dec 2021 | |
| MPM BioImpact LLC |
13F
|
Company |
0.25%
|
142,437
|
$6,074,000 | — | 31 Dec 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.24%
|
137,646
|
$5,869,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
134,800
|
$5,748,000 | — | 31 Dec 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.21%
|
123,600
|
$5,270,000 | — | 31 Dec 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.21%
|
121,161
|
$5,166,000 | — | 31 Dec 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.2%
|
114,625
|
$4,888,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.19%
|
110,361
|
$4,706,000 | — | 31 Dec 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.16%
|
94,433
|
$4,026,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.16%
|
90,431
|
$3,856,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.11%
|
60,694
|
$2,588,000 | — | 31 Dec 2021 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.1%
|
60,000
|
$2,558,000 | — | 31 Dec 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.1%
|
57,894
|
$2,469,000 | — | 31 Dec 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
53,589
|
$2,285,000 | — | 31 Dec 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
53,540
|
$2,283,000 | — | 31 Dec 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.09%
|
52,629
|
$2,245,000 | — | 31 Dec 2021 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.09%
|
51,600
|
$2,200,000 | — | 31 Dec 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.08%
|
48,987
|
$2,089,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
46,906
|
$2,000,000 | — | 31 Dec 2021 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.08%
|
46,450
|
$1,981,000 | — | 31 Dec 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.07%
|
43,000
|
$1,834,000 | — | 31 Dec 2021 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q1 2022
As of 31 Mar 2022,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,933,803 shares.
The largest 10 holders included
Valor Management LLC, FMR LLC, Vivo Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, venBio Partners LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Blackstone Inc., and STATE STREET CORP.
This page lists
169
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
138
Q1 2022 holders
168
Holder diff
30
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.